Microbiome research company Clinical Microbiomics has acquired MS-Omics, a leading provider based in Denmark. With this acquisition, Clinical Microbiomics hopes to further advance its systems biology platform and help researchers worldwide understand the microbiome and how to impact health and disease. Anders Grøn, CEO at Clinical Microbiomics, commented: “There is an unmet need in the […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!